CGI Pharmaceuticals News

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. announced today that the company will be webcasting its corporate presentation at two upcoming investor conferences: the Jefferies Global Healthcare Conference in New York and the Goldman Sachs Healthcare Conference in Rancho Palos Verdes, California.

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. announced today that the Marketing Authorisation Application for cobicistat, submitted on April 26, 2012, has been validated by the European Medicines Agency .

This week, the U.S. Food and Drug Administration will consider allowing an anti-HIV drug to be promoted to otherwise healthy, HIV-free people as a purely preventative measure for the first time.

Truvada, a once-daily antiretroviral pill, is effective for preventing sexual transmission of HIV and should be approved as post-exposure prophylaxis, or PrEP, a Food and Drug Administration advisory committee voted last week.

Netflix, Inc. : Needham believes that increases in Netflix's domestic streaming margins will be largely offset by a decline in higher margin DVD subscription revenues.

In trading on Monday, the Biotech ETF is outperforming other ETFs, up about 0.5% on the day.

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration has voted 13 to 1 in support of approval of the Quad, a complete single tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate, for the treatment of HIV-1 infection ... (more)

Shares of Gilead continue to rise subsequent to Thursday's FDA advisory panel approval of the firm's HIV drug Truvada for use as a preventative measure in high-risk individuals.

A mailer from the AIDS Healthcare Foundation opposing Gilead Sciences' FDA application to extend Truvada's use to prevent the AIDS virus.

Plus, the gloves are off as GlaxoSmithKline has mounted a hostile offer for its long-time partner Human Genome Sciences.

FOSTER CITY, Calif. -- -- Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas.